The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms
- 2 December 2016
- journal article
- other
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 58 (8) , 1914-1921
Abstract
Gene expression profiling in Philadelphia-negative chronic myeloproliferative neoplasms (MPNs) have unraveled significant deregulation of several immune and inflammation genes of potential importance for clonal evolution. Other mechanisms might be downregulation of major histocompatibility class I and II genes used by tumor cells to escape antitumor T-cell-mediated immune responses. Several genes encoding human leukocyte antigen (HLA) class I and II molecules have been shown to be significantly downregulated. Upregulation of HLA genes is considered one of the mechanisms of action of interferon (IFN)-alpha2, but regulation of these genes during IFN-alpha2 treatment in MPNs has never been studied. Our findings show a significant upregulation of several HLA genes of importance for tumor immune surveillance by IFN-alpha2 treatment in MPNs. This mechanism might enhance the cytotoxic potential of immune cells against MPNs and explain the induction of minimal residual disease by IFN-alpha2 treatment in these patients.Keywords
Funding Information
- Agnes og Poul Friis Fond
- Familien Hede Nielsens Fond
- Fonden til Lægevidenskabens Fremme
- Civilingeniør Bent Bøgh og Hustru Inge Bøghs Fond
- Københavns Universitetsfond
- Fabrikant Einar Willumsens Mindelegat
- Steenbeck’s Legat
This publication has 65 references indexed in Scilit:
- Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosisAmerican Journal of Hematology, 2013
- Therapy of chronic myeloid leukaemia can benefit from the activation of stem cells: simulation studies of different treatment combinationsBritish Journal of Cancer, 2012
- Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?Blood, 2012
- The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?Haematologica, 2011
- Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cellsLeukemia, 2010
- Efficacious Immune Therapy in Chronic Myelogenous Leukemia (CML) Recognizes Antigens That Are Expressed on CML Progenitor CellsCancer Research, 2010
- The Myeloproliferative DisordersNew England Journal of Medicine, 2006
- IFN-α promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatmentBlood, 2004
- DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomasCarcinogenesis, 2001
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997